Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Adagio Medical Holdings, Inc.

NASDAQ: ADGM · Industrial Applications and Services · 6 alerts · CIK 2006986

Share price
$1.61Close, Nov 16
Market cap
$1.58M
Shares outstanding
983.43KLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Adagio Medical Holdings, Inc. filings on SEC EDGAR ↗

8:05 AM ET 10-Q
Financial Results

Adagio Medical Holdings Q3 2026 Results: Turns Profitable, Net Income $17.8M

Adagio Medical Holdings, Inc. reported a significant decrease in cash and cash equivalents from $17.1 million at the end of 2025 to $3.1 million as of September 30, 2026. The company highlighted substantial risks regarding its ability to continue as a going concern and is exploring strategic alternatives to maximize stockholder value.

Key figure
Net income $17.8M
8:03 AM ET 8-K
Financial Results

Adagio Medical Holdings Financial Results

Adagio Medical reported Q3 2026 financial results, highlighting a net income of $17.8 million primarily driven by a $23.0 million gain from the change in fair value of warrant liabilities. The company also announced that its Board of Directors has initiated a formal process to explore strategic alternatives to maximize shareholder value while continuing clinical progress on its vCLAS Ultra System.

Term
Q3 2026

“The third quarter was defined by progress in the clinical and regulatory programs that we believe are the foundation for the value of Adagio and our ULTA platform. Our PMA application for the vCLAS Ventricular Ablation System remains under FDA review, and we initiated the vCLAS Ultra IDE study, which builds on the FULCRUM-VT results with a faster, more maneuverable next-generation catheter.”

Todd Usen, Chief Executive Officer of Adagio Medical

“As the Board’s review of strategic alternatives continues, we have aligned our cost structure around these prioritized programs and remain focused on maximizing value for our shareholders.”

Todd Usen, Chief Executive Officer of Adagio Medical

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.